Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The "physical barrier for clot formation" refers to the structural components that form at a site of blood vessel injury to prevent blood loss and block entry of pathogens. This barrier is primarily composed of a platelet plug reinforced by an insoluble meshwork of fibrin fibers, resulting from the coordinated actions of platelets and plasma proteins during hemostasis. This target is not a single molecule but rather describes the composite structure formed by cellular (platelet) and proteinaceous (fibrin) elements during normal hemostatic response.
Varied, depending on the drug. Antiplatelet drugs inhibit platelet aggregation; anticoagulants inhibit the coagulation cascade; thrombolytics dissolve existing clots.
2 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Physical Barrier for Clot Formation.